首页> 外文OA文献 >Extraction, purification, characterization, anticoagulant activity, and anticoagulant mechanism of polysaccharides from the heads of Hypomesus olidus
【2h】

Extraction, purification, characterization, anticoagulant activity, and anticoagulant mechanism of polysaccharides from the heads of Hypomesus olidus

机译:从脱粒性Olidus头部的多糖提取,纯化,表征,抗凝血机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Abstract The aim of this work was to extract, isolate, and purify polysaccharides from the heads of Hypomesus olidus and to evaluate their anticoagulant activities and anticoagulant mechanisms. Response surface methodology was used to optimize the extraction conditions for ultrasonic‐assisted extraction of polysaccharides from the heads of Hypomesus olidus. The optimal extraction conditions consisted of ultrasonic power of 275 W, ultrasonic time of 50 min, and solid–liquid ratio of 5 ml/g, giving the yield of crude polysaccharides (GYT) of 7.73 ± 0.042%. Three polysaccharide fractions, GYT‐1, GYT‐2, and GYT‐3 were purified from GYT by using DEAE‐cellulose‐52 column and Sephadex G‐100 column for anticoagulant activities. The results showed that two doses (2 and 4 mg/ml) of GYT‐1 and GYT‐3 could significantly prolong (p  .05). In addition, anticoagulation mechanism of polysaccharides from the heads of Hypomesus olidus (GYT‐3) was evaluated. The results showed that the anticoagulant activity of GYT‐3 was based on their binding with antithrombin AT‐III. And the inhibitory effects of GYT‐3 on factor IIa and Xa were related to the concentration of AT‐III in plasma. This study may provide a new and promising anticoagulant drug.
机译:摘要目标这项工作是为了提取,分离和纯化多糖从公鱼属olidus的头,并评估其抗凝血活性和抗凝血机制。响应面分析法被用来优化从公鱼属olidus的头部多糖的超声辅助提取的提取条件。最佳提取条件由275 W的超声功率,50分钟的超声波的时间,和5毫升/克固液比的,给予的7.73±0.042%的粗多糖(GYT)的产率。三个多糖组分,GYT-1,GYT-2,和GYT-3通过使用DEAE-纤维素-52柱和Sephadex G-100柱进行抗凝血活性从GYT纯化。结果表明,两种剂量的(2和4毫克/毫升)GYT-1和GYT-3的能显著延长(第0.05)。另外,从公鱼属olidus的头部多糖的抗凝机构(GYT-3)进行评价。结果表明,GYT-3的抗凝血活性是基于其与抗凝血酶AT-III的结合。和GYT-3对因子IIa和XA的抑制作用均与AT-III的血浆中的浓度。这项研究提供了新的有为抗凝药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号